Status:
WITHDRAWN
Vitamin C for the Prevention of UTI in Women Who Undergo Elective GYN Surgeries
Lead Sponsor:
American University of Beirut Medical Center
Conditions:
Catheter-Associated Urinary Tract Infection, Ascorbic Acid
Eligibility:
FEMALE
18+ years
Phase:
EARLY_PHASE1
Brief Summary
This open-label randomized trial aims at assessing the role of Vitamin C pills in the prevention of catheter-associated urinary tract infections in women undergoing elective gynecological surgeries.
Eligibility Criteria
Inclusion
- Non pregnant women at least 18 years of age visiting the Preadmission unit (PAU) or the OBGYN floor (7N), presenting for elective GYN surgery at the American University of Beirut Medical Center (AUBMC).
Exclusion
- Any women with the following:
- Nephrolithiasis
- Congenital anomaly or neurogenic bladder
- Allergy to ascorbic acid
- Who require therapeutic anticoagulant medicine during the 6 weeks after surgery
- Surgery did involve a fistula repair or a vaginal mesh removal
- Positive Urinalysis in the PAU
- Recurrent UTI's
- Diabetes
- G6PD
- Hemochromatosis
- Renal disorders
- Patients already taking Vitamin C supplementation will also be excluded from the study.
Key Trial Info
Start Date :
August 8 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 12 2019
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT03800667
Start Date
August 8 2018
End Date
July 12 2019
Last Update
July 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
American University of Beirut Medical Center
Beirut, Lebanon